CURONZ

curonz-logo

Curonz is a clinical stage biotechnology company with a drug portfolio covering the peptide family, Neural Regeneration Peptides (NRPs), which were discovered by Curonz's founding Director, Dr Frank Sieg and where precursor compounds to our clinical molecule NRP2945 were first patented back in 2001. We currently have offices in Delaware, NZ and Australia. We have completed Clinical Phase I in Australia for our lead drug candidate NRP2945 with 49 healthy volunteers. Currently, we are studing NR... P2945 in a small Phase II proof of concept study in adults with typical absence epilepsy which is due to finish mid 2019. We are looking for investment to conduct a clinical phase 2 study in Temporal Lobe Epilepsy as well as has plans for a clinical phase II study in Lennox-Gastaut Syndrome children. NRP2945 exerts its activity via agonism of a novel CXCR4 receptor complex in an ultra-potent manner with no off-target effects. Curonz aims to licensing the platform of compounds or reach other commercial arrangements to provide a clear pathway forward to bring this promising therapeutic treatment as quickly as possible to patients.

#SimilarOrganizations #People #Website #More

CURONZ

Social Links:

Industry:
Biotechnology

Founded:
2010-01-01

Address:
Dover, Delaware, United States

Country:
United States

Website Url:
http://www.curonz.com

Total Employee:
1+

Status:
Active

Contact:
64 21 500 453

Email Addresses:
[email protected]

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Dreamscape Networks


Similar Organizations

caelum-biosciences-logo

Caelum Biosciences

Caelum Biosciences, Inc.is a clinical-stage biotechnology company.

Founder


not_available_image

Frank Sieg

Official Site Inspections

http://www.curonz.com Semrush global rank: 6.18 M Semrush visits lastest month: 1.31 K

  • Host name: ip-112-109-82-97.webhost.co.nz
  • IP address: 112.109.82.97
  • Location: New Zealand
  • Latitude: -41
  • Longitude: 174
  • Timezone: Pacific/Auckland

Loading ...

More informations about "CuroNZ"

Curonz Limited

Curonz has completed a successful Phase I safety trial in healthy volunteers. We recently completed a small Phase II trial in patients with Absence Epilepsy. read more. Lennox Gastaut …See details»

About Curonz Limited

About Curonz . Curonz is a clinical stage biotechnology company with a patent portfolio and platform of peptide / peptidomimetic drugs relevant for the treatment of severe …See details»

CuroNZ - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 64 21 500 453 Curonz is a clinical stage biotechnology company with a drug portfolio covering the peptide family, Neural Regeneration …See details»

Curonz - Overview, News & Similar companies | ZoomInfo.com

Curonz was founded in 2009 by Dr. Frank Sieg who discovered the drug candidate portfolio called Neural Regeneration Peptides (NRPs) in Germany. ... Explore Complete Organization …See details»

CuroNZ - LinkedIn

CuroNZ is aiming to change the scope of therapeutic treatment possibilities for refractory epilepsies and difficult to treat encephalopathies by putting emphasis on targeting seizures and co ...See details»

CURONZ LIMITED Company Profile - Dun & Bradstreet

Curonz limited. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / new zealand / wellsford / …See details»

Curonz's Mission

About Curonz Directors Advisory Board. Our Mission . To create and deliver a human therapeutic with groundbreaking neurological disease abrogating effects. To develop and produce, to the …See details»

CuroNZ Ltd. - Drug pipelines, Patents, Clinical trials - Synapse

Explore CuroNZ Ltd. with its drug pipeline, therapeutic area, technology platform, 3 literature, Disease Domain:Nervous System Diseases, Endocrinology and Metabolic Disease, Immune …See details»

CURONZ LIMITED - WELLSFORD - NEW ZEALAND - Companies NZ

Dec 18, 2009 CURONZ LIMITED has the company number:2377756 and the NZ business number: 9429031726719. Overview . CURONZ LIMITED is a NZ Limited Company from …See details»

CuroNZ Ltd - VentureRadar

CuroNZ Ltd VentureRadar profile. Find out more about CuroNZ Ltd, Biotechnology, DNA, RNA and Peptide Therapies. All; Ranked; Organisation Names; Apps and Links. Homepage …See details»

CuroNZ - Company Profile - Tracxn

Feb 25, 2025 CuroNZ, through NRP, is focused on drug development in CNS and ophthalmology across the following indications: Lennox Gastaut Syndrome, Motoneurone …See details»

CuroNZ - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Curonz is a clinical stage biotechnology company. Start Free Trial . Chrome ExtensionSee details»

Contact Curonz Limited

We have registered offices in USA, Western Australian and New Zealand (Ruakura Campus, Hamilton).See details»

CuroNZ - Products, Competitors, Financials, Employees, …

CuroNZ is a small Biotechnology start-up company with a drug patent portfolio covering the peptide family, Neural Regeneration Peptides (NRPs). The company plans to develop our drug …See details»

Curonz Company Profile | Management and Employees List

Find contact information for Curonz. Learn about their Manufacturing market share, competitors, and Curonz's email format.See details»

CURONZ HOLDINGS COMPANY LIMITED - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for CURONZ HOLDINGS COMPANY LIMITED of Wellsford. Get the latest business insights from Dun & …See details»

CuroNZ Ltd - VentureRadar

CuroNZ Ltd VentureRadar profile. Find out more about CuroNZ Ltd, Biotechnology, DNA, RNA and Peptide Therapies.See details»

CuroNZ Ltd.: Drug pipelines, Patents, Clinical trials - Synapse

Sep 23, 2023 Explore CuroNZ Ltd. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Endocrinology and Metabolic Disease ...See details»

What is Curonz? Company Culture, Mission, Values | Glassdoor

See what employees say it's like to work at Curonz. Salaries, reviews, and more - all posted by employees working at Curonz.See details»

Research Overview at Curonz Limited

Research Overview . We have completed extensive preclinical work, Phase I safety and are readying NRP2945 for clinical Phase II studies. Clinical Studies Planned and Completed:See details»

linkstock.net © 2022. All rights reserved